U.S. flag

An official website of the United States government

NM_000038.6(APC):c.3183_3187del (p.Lys1061_Gln1062insTer) AND Hereditary cancer-predisposing syndrome

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Mar 31, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000162768.17

Allele description [Variation Report for NM_000038.6(APC):c.3183_3187del (p.Lys1061_Gln1062insTer)]

NM_000038.6(APC):c.3183_3187del (p.Lys1061_Gln1062insTer)

Gene:
APC:APC regulator of WNT signaling pathway [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
5q22.2
Genomic location:
Preferred name:
NM_000038.6(APC):c.3183_3187del (p.Lys1061_Gln1062insTer)
HGVS:
  • NC_000005.10:g.112838777_112838781del
  • NG_008481.4:g.151257_151261del
  • NM_000038.6:c.3183_3187delMANE SELECT
  • NM_001127510.3:c.3183_3187del
  • NM_001127511.3:c.3129_3133del
  • NM_001354895.2:c.3183_3187del
  • NM_001354896.2:c.3237_3241del
  • NM_001354897.2:c.3213_3217del
  • NM_001354898.2:c.3108_3112del
  • NM_001354899.2:c.3099_3103del
  • NM_001354900.2:c.3060_3064del
  • NM_001354901.2:c.3006_3010del
  • NM_001354902.2:c.2910_2914del
  • NM_001354903.2:c.2880_2884del
  • NM_001354904.2:c.2805_2809del
  • NM_001354905.2:c.2703_2707del
  • NM_001354906.2:c.2334_2338del
  • NM_001407446.1:c.3267_3271delACAAA
  • NM_001407447.1:c.3237_3241delACAAA
  • NM_001407448.1:c.3237_3241delACAAA
  • NM_001407449.1:c.3237_3241delACAAA
  • NM_001407450.1:c.3183_3187delACAAA
  • NM_001407451.1:c.3162_3166delACAAA
  • NM_001407452.1:c.3153_3157delACAAA
  • NM_001407453.1:c.3006_3010delACAAA
  • NM_001407454.1:c.2934_2938delACAAA
  • NM_001407455.1:c.2934_2938delACAAA
  • NM_001407456.1:c.2934_2938delACAAA
  • NM_001407457.1:c.2934_2938delACAAA
  • NM_001407458.1:c.2880_2884delACAAA
  • NM_001407459.1:c.2880_2884delACAAA
  • NM_001407460.1:c.2880_2884delACAAA
  • NM_001407467.1:c.2796_2800delACAAA
  • NM_001407469.1:c.2796_2800delACAAA
  • NM_001407470.1:c.2334_2338delACAAA
  • NM_001407471.1:c.2031_2035delACAAA
  • NM_001407472.1:c.2031_2035delACAAA
  • NP_000029.2:p.Gln1062Terfs
  • NP_000029.2:p.Lys1061_Gln1062insTer
  • NP_001120982.1:p.Gln1062Terfs
  • NP_001120982.1:p.Lys1061_Gln1062insTer
  • NP_001120983.1:p.Gln1062Terfs
  • NP_001120983.2:p.Lys1043_Gln1044insTer
  • NP_001341824.1:p.Lys1061_Gln1062insTer
  • NP_001341825.1:p.Lys1079_Gln1080insTer
  • NP_001341826.1:p.Lys1071_Gln1072insTer
  • NP_001341827.1:p.Lys1036_Gln1037insTer
  • NP_001341828.1:p.Lys1033_Gln1034insTer
  • NP_001341829.1:p.Lys1020_Gln1021insTer
  • NP_001341830.1:p.Lys1002_Gln1003insTer
  • NP_001341831.1:p.Lys970_Gln971insTer
  • NP_001341832.1:p.Lys960_Gln961insTer
  • NP_001341833.1:p.Lys935_Gln936insTer
  • NP_001341834.1:p.Lys901_Gln902insTer
  • NP_001341835.1:p.Lys778_Gln779insTer
  • NP_001394375.1:p.Gln1090Terfs
  • NP_001394376.1:p.Gln1080Terfs
  • NP_001394377.1:p.Gln1080Terfs
  • NP_001394378.1:p.Gln1080Terfs
  • NP_001394379.1:p.Gln1062Terfs
  • NP_001394380.1:p.Gln1055Terfs
  • NP_001394381.1:p.Gln1052Terfs
  • NP_001394382.1:p.Gln1003Terfs
  • NP_001394383.1:p.Gln979Terfs
  • NP_001394384.1:p.Gln979Terfs
  • NP_001394385.1:p.Gln979Terfs
  • NP_001394386.1:p.Gln979Terfs
  • NP_001394387.1:p.Gln961Terfs
  • NP_001394388.1:p.Gln961Terfs
  • NP_001394389.1:p.Gln961Terfs
  • NP_001394396.1:p.Gln933Terfs
  • NP_001394398.1:p.Gln933Terfs
  • NP_001394399.1:p.Gln779Terfs
  • NP_001394400.1:p.Gln678Terfs
  • NP_001394401.1:p.Gln678Terfs
  • LRG_130t1:c.3183_3187del
  • LRG_130t2:c.3183_3187del
  • LRG_130t3:c.3183_3187del
  • LRG_130:g.151257_151261del
  • LRG_130p1:p.Gln1062Terfs
  • LRG_130p2:p.Gln1062Terfs
  • LRG_130p3:p.Gln1062Terfs
  • NC_000005.9:g.112174471_112174475del
  • NC_000005.9:g.112174474_112174478del
  • NM_000038.4:c.3183_3187delACAAA
  • NM_000038.5:c.3183_3187delACAAA
  • NM_000038.6:c.3183_3187delACAAAMANE SELECT
  • NM_001127510.1:c.3183_3187delACAAA
  • NM_001127511.1:c.3183_3187delACAAA
  • NR_176365.1:n.3018_3022delACAAA
  • NR_176366.1:n.3437_3441delACAAA
  • p.Gln1062*
  • p.Q1062*
Links:
Genetic Testing Registry (GTR): GTR000330983; dbSNP: rs587779352
NCBI 1000 Genomes Browser:
rs587779352
Molecular consequence:
  • NM_000038.6:c.3183_3187del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001127510.3:c.3183_3187del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001127511.3:c.3129_3133del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354895.2:c.3183_3187del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354896.2:c.3237_3241del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354897.2:c.3213_3217del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354898.2:c.3108_3112del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354899.2:c.3099_3103del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354900.2:c.3060_3064del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354901.2:c.3006_3010del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354902.2:c.2910_2914del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354903.2:c.2880_2884del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354904.2:c.2805_2809del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354905.2:c.2703_2707del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354906.2:c.2334_2338del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407446.1:c.3267_3271delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407447.1:c.3237_3241delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407448.1:c.3237_3241delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407449.1:c.3237_3241delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407450.1:c.3183_3187delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407451.1:c.3162_3166delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407452.1:c.3153_3157delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407453.1:c.3006_3010delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407454.1:c.2934_2938delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407455.1:c.2934_2938delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407456.1:c.2934_2938delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407457.1:c.2934_2938delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407458.1:c.2880_2884delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407459.1:c.2880_2884delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407460.1:c.2880_2884delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407467.1:c.2796_2800delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407469.1:c.2796_2800delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407470.1:c.2334_2338delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407471.1:c.2031_2035delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407472.1:c.2031_2035delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407446.1:c.3267_3271delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407447.1:c.3237_3241delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407448.1:c.3237_3241delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407449.1:c.3237_3241delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407450.1:c.3183_3187delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407451.1:c.3162_3166delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407452.1:c.3153_3157delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407453.1:c.3006_3010delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407454.1:c.2934_2938delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407455.1:c.2934_2938delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407456.1:c.2934_2938delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407457.1:c.2934_2938delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407458.1:c.2880_2884delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407459.1:c.2880_2884delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407460.1:c.2880_2884delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407467.1:c.2796_2800delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407469.1:c.2796_2800delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407470.1:c.2334_2338delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407471.1:c.2031_2035delACAAA - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407472.1:c.2031_2035delACAAA - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000213245Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Mar 31, 2022)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

Citation Link,

SCV000905975Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 15, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Germline mutations of the APC gene in Korean familial adenomatous polyposis patients.

Won YJ, Park KJ, Kwon HJ, Lee JH, Kim JH, Kim YJ, Chun SH, Han HJ, Park JG.

J Hum Genet. 1999;44(2):103-8.

PubMed [citation]
PMID:
10083733

Founder mutation in familial adenomatous polyposis (FAP) in the Balearic Islands.

González S, Blanco I, Campos O, Julià M, Reyes J, Llompart A, Cabeza E, Germà JR, Obrador A, Capellá G.

Cancer Genet Cytogenet. 2005 Apr 1;158(1):70-4.

PubMed [citation]
PMID:
15771908
See all PubMed Citations (10)

Details of each submission

From Ambry Genetics, SCV000213245.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (9)

Description

The c.3183_3187delACAAA pathogenic mutation (also known as p.Q1062*), located in coding exon 15 of the APC gene, results from a deletion of 5 nucleotides at nucleotide positions 3183 to 3187. This changes the amino acid from a glutamine to a stop codon within coding exon 15. This mutation has been identified in numerous individuals and families from a variety of ethnic backgrounds with classic familial adenomatous polyposis (FAP), including some individuals with extra colonic manifestations including desmoid tumors, gastrointestinal cancers, papillary thyroid cancer, congenital hypertrophy of the retinal pigment epithelium (CHRPE), and epidermal cysts (Miyoshi Y et al. Proc. Natl. Acad. Sci. U.S.A. 1992 May;89:4452-6; Won YJ et al. J. Hum. Genet. 1999;44:103-8; González S et al. Cancer Genet. Cytogenet. 2005 Apr;158:70-4; Kim DW et al. Hum. Mutat. 2005 Sep;26:281; Friedl W & Aretz S. Hered. Cancer Clin. Pract. 2005 Sep;3:95-114; Plawski A & Slomski R. J. Appl. Genet. 2008;49:407-14; Fostira F et al. BMC Cancer. 2010 Jul;10:389; Rivera B et al. Ann. Oncol. 2011 Apr;22:903-9; Kerr SE et al. J. Mol. Diagn. 2013 Jan;15:31-43; Papp J et al. Fam. Cancer. 2016 Jan;15(1):85-97; Dahl NA et al. J. Pediatr. Hematol. Oncol. 2016 07;38(5):e154-7). Of note, this alteration is also described as a truncation at codon 1061 or codon 1060, and as c.3221_3225delACAAA in the literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV000905975.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant deletes 5 nucleotides in exon 16 of the APC gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. This variant has been identified in 1/250490 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of APC function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 19, 2024